Medication in patients with hypertension in rural Liaoning Province Survey.docVIP

 PAGE \* MERGEFORMAT 8 Medication in patients with hypertension in rural Liaoning Province Survey [Keywords:] in rural areas; Hypertension; drug Abstract: Objective To understand the Liaoning Province, the situation in rural areas, high blood pressure medication. Methods A random sample survey methods, and households, to Zhuanghe and Benxi County, Liaoning Province in 4397, and 14802 people hypertension medication survey. The results uncovered a total of 444 hypertensive patients, the sick rate of 30%, of which 768% of the hypertensive patients with a single antihypertensive drug treatment, 684% of patients taking Combivir. Most of the blood pressure taking antihypertensive drugs for the compound tablets (569%), Beijing Hypotensive No.0 (149%) and cards drag Plymouth (102%). Calcium channel blockers (34%) and diuretics (08%) rate was significantly lower than other regions. Conclusion Most patients with hypertension in rural areas to take low-cost compound preparation, joint drug levels and drug use structure and ‘Chinese Hypertension prevention and control guidelines’ requirements there is a huge gap. Keywords: rural; hypertension; drug Investigation on medicine usage status of hypertenoron patients in villages of Liaoning province Abstract: Objective To find out the medicine use of hypentension patients of Liaoning province.Methods The 14802 persons from 4397 families in Zhuanghe and Benxi, two counties of Liaoning province, were investigated on the condition of high blood pressure and their medication by using random sampling method.Results Four hundred and fourty four high blood pressure patients were found out, and the morbidity rate was 3.0% .768% high blood pressure patients adopted only one hypertensive drug to control the blood pressure and 684% patients took the fixeddose combination.The most useful medicine order was the compound Reserpine (569%), the Peking step-down No.0 (149%), and the Captopril (102%). The utilization rates of Calcium antagon